Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Xencor Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP4059514A1 | Application | HETERODIMERE ANTIKÖRPER ZUR BINDUNG VON CD3 UND TUMORANTIGENEN | A61K2039/505; A61P35/02; C07K16/2809; C07K16/2866; C07K16/2896; C07K16/30; C07K16/468; C07K2317/24; C07K2317/31; C07K2317/35; C07K2317/526; C07K2317/528; C07K2317/55; C07K2317/565; C07K2317/60; C07K2317/622; C07K2317/73; C07K2317/90; C07K2317/92; C07K2317/94 | September 21, 2022 |
| WO2022192586A1 | Application | HETERODIMERIC ANTIBODIES THAT BIND CD3 AND GPC3 | A61K2039/505; A61P35/00; C07K16/2809; C07K16/303; C07K2317/31; C07K2317/50; C07K2317/565; C07K2317/60; C07K2317/73 | September 15, 2022 |
| WO2022192403A1 | Application | HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6 | A61K2039/505; A61K2039/507; A61P35/00; C07K16/28; C07K16/2809; C07K16/468; C07K2317/24; C07K2317/31; C07K2317/33; C07K2317/54; C07K2317/55; C07K2317/622; C07K2317/73; C07K2317/92; C07K2317/94; C12N15/63 | September 15, 2022 |
| US20220281964A1 | Application | Fc VARIANTS WITH ALTERED BINDING TO FcRn | A61K2039/505; C07K14/7151; C07K16/082; C07K16/18; C07K16/22; C07K16/241; C07K16/2863; C07K16/2866; C07K16/2893; C07K16/2896; C07K16/32; C07K16/4291; Y02A50/30 | September 08, 2022 |
| US11434295B2 | Grant | Methods and compositions for inhibiting CD32B expressing cells | A61K2039/505; C07K16/00; C07K16/2803; C07K16/283; C07K16/2851; C07K16/2878; C07K2317/24; C07K2317/31; C07K2317/52; C07K2317/524; C07K2317/53; C07K2317/71; C07K2317/72; C07K2317/73; C07K2317/732; C07K2317/734; C07K2317/76; C07K2317/77; C07K2317/92 | September 06, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer